Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rosell

Showing results (121-130 of 265) with videos related to

Pageof 27
Sort By:
Acta Otorrinolaringologica Espanola|September 1, 1989
[Review of 156 myringoplasties]M R Rosell, E Figuerola, M Liern, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1993
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancerJ Carles, R Rosell, A Ariza, et al.
Tumori|August 31, 1987
The role of combination cyclophosphamide, doxorubicin and cisplatin (CAP) chemotherapy in advanced non-small-cell lung cancerR Rosell Costa, A Abad-Esteve, J Roig Cutilles, et al.
American Journal of Clinical Oncology|June 1, 1987
A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancerR Rosell, A Abad-Esteve, J Morera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary siteC Balaña, J-L Manzano, I Moreno, et al.
Medicina Clinica|December 6, 1986
[Evaluation of an antiemetic regimen with a high-dose metoclopramide, dexamethasone and diphenhydramine combination in chemotherapy regimens with cisplatin]A Abad-Esteve, R Rosell, I Moreno, et al.
Cancer|May 15, 1991
A phase II study of days 1 and 8 cisplatin and recombinant alpha-2B interferon in advanced non-small cell lung cancerR Rosell, J Carles, A Ariza, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 27, 2007
Clinical course of high-grade glioma patients with a "biopsy-only" surgical approach: a need for individualised treatmentC Balaña, J Capellades, P Teixidor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
Emerging Options and Future Strategies in Immunotherapy for Advanced Lung Squamous Cell CarcinomaY Wang, R Rosell, F R Hirsch, et al.
The Veterinary Record|June 29, 2011
Investigations of pestivirus infection in wild Caprinae in EuropeL Fernández-Sirera, O Cabezón, L Rossi, et al.
Pageof 27

Showing results (121-130 of 265) with videos related to

Sort By:
Pageof 27
Acta Otorrinolaringologica Espanola|September 1, 1989
[Review of 156 myringoplasties]M R Rosell, E Figuerola, M Liern, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1993
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancerJ Carles, R Rosell, A Ariza, et al.
Tumori|August 31, 1987
The role of combination cyclophosphamide, doxorubicin and cisplatin (CAP) chemotherapy in advanced non-small-cell lung cancerR Rosell Costa, A Abad-Esteve, J Roig Cutilles, et al.
American Journal of Clinical Oncology|June 1, 1987
A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancerR Rosell, A Abad-Esteve, J Morera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary siteC Balaña, J-L Manzano, I Moreno, et al.
Medicina Clinica|December 6, 1986
[Evaluation of an antiemetic regimen with a high-dose metoclopramide, dexamethasone and diphenhydramine combination in chemotherapy regimens with cisplatin]A Abad-Esteve, R Rosell, I Moreno, et al.
Cancer|May 15, 1991
A phase II study of days 1 and 8 cisplatin and recombinant alpha-2B interferon in advanced non-small cell lung cancerR Rosell, J Carles, A Ariza, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 27, 2007
Clinical course of high-grade glioma patients with a "biopsy-only" surgical approach: a need for individualised treatmentC Balaña, J Capellades, P Teixidor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
Emerging Options and Future Strategies in Immunotherapy for Advanced Lung Squamous Cell CarcinomaY Wang, R Rosell, F R Hirsch, et al.
The Veterinary Record|June 29, 2011
Investigations of pestivirus infection in wild Caprinae in EuropeL Fernández-Sirera, O Cabezón, L Rossi, et al.
Pageof 27